LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Science
• Education
• Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

trail, cells, onctic, tic, article, cell, tumor, gene, pubmed, cancer, google, scholar, death, trailinducing, compounds, human, figure, activity, cas, reporter, hct, small, apoptosis, normal, induction, levels, foxoa, induce, analysis, molecule, receptor, ligand, vivo, studies, study, screen, compound, molecules, promoter, dose, treated, content, anticancer, allen, dicker, eldeiry, clinical, antitumor, selection, mechanism,

Topics {✒️}

tumour-necrosis factor superfamily trail-independent pro-apoptotic effects akt/foxo3a/trail-dependent manner onc201/tic10-induced cell death identify trail-inducing compounds trail pathway-inducing compound dna-damaging chemotherapy doxorubicin lead trail-inducing compound top trail-inducing compounds extracellular signal-regulated kinases trail-independent apoptotic activity candidate trail-inducing compounds leukemic stem/progenitor cells bcr-abl mediate suppression hrp-conjugated secondary antibody unique anti-cancer agent full size image tumor cell-specific targeting selected trail-inducing compounds improve trail-inducing compounds validation trail-inducing compounds tic-treated xenograft tumors related subjects antibody targeting trail-r1 onc201/tic10 potently inhibited trail-mediated cell death approved anti-cancer compounds onc201/tic10-induced trail onc201/tic10-induced dr5 anti-gamma h2ax antibody open access license monocyte-mediated tumoricidal activity restore anti-tumor immunity potent anti-cancer activity onc201/tic10 induce trail improves efficacy-limiting properties receptor-selective variant dr5 onc201/tic10 upregulate trail classic er stress-inducer refractory colorectal cancer cell-based reporter system bio-rad protein assay trail-inducing compounds potent anti-tumor effects exclusively activate foxo3a article download pdf inducing cell death inducing high levels dr5 gene promoter molecule induced apoptosis

Questions {❓}

• A Better TRAIL Variant for Tumor Cell-Specific Targeting?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway
         description:We previously reported the identification of ONC201/TIC10, a novel small molecule inducer of the human TRAIL gene that improves efficacy-limiting properties of recombinant TRAIL and is in clinical trials in advanced cancers based on its promising safety and antitumor efficacy in several preclinical models. We performed a high throughput luciferase reporter screen using the NCI Diversity Set II to identify TRAIL-inducing compounds. Small molecule-mediated induction of TRAIL reporter activity was relatively modest and the majority of the hit compounds induced low levels of TRAIL upregulation. Among the candidate TRAIL-inducing compounds, TIC9 and ONC201/TIC10 induced sustained TRAIL upregulation and apoptosis in tumor cells in vitro and in vivo. However, ONC201/TIC10 potentiated tumor cell death while sparing normal cells, unlike TIC9, and lacked genotoxicity in normal fibroblasts. Investigating the effects of TRAIL-inducing compounds on cell signaling pathways revealed that TIC9 and ONC201/TIC10, which are the most potent inducers of cell death, exclusively activate Foxo3a through inactivation of Akt/ERK to upregulate TRAIL and its pro-apoptotic death receptor DR5. These studies reveal the selective activity of ONC201/TIC10 that led to its selection as a lead compound for this novel class of antitumor agents and suggest that ONC201/TIC10 is a unique inducer of the TRAIL pathway through its concomitant regulation of the TRAIL ligand and its death receptor DR5.
         datePublished:2015-05-01T00:00:00Z
         dateModified:2024-10-18T00:00:00Z
         pageStart:1
         pageEnd:10
         license:https://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12943-015-0346-9
         keywords:
            ONC201
            TIC10
            TRAIL
            TRAIL-inducing compound
            TNF-related apoptosis-inducing ligand
            DR5
            Foxo3a
            Gene regulation
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig7_HTML.gif
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:14
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Joshua E Allen
               affiliation:
                     name:University of Pennsylvania School of Medicine
                     address:
                        name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
                     name:Current affiliation: Oncoceutics, Inc.
                     address:
                        name:Current affiliation: Oncoceutics, Inc., Hummelstown, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gabriel Krigsfeld
               affiliation:
                     name:University of Pennsylvania School of Medicine
                     address:
                        name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luv Patel
               affiliation:
                     name:University of Pennsylvania School of Medicine
                     address:
                        name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Patrick A Mayes
               affiliation:
                     name:University of Pennsylvania School of Medicine
                     address:
                        name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David T Dicker
               affiliation:
                     name:University of Pennsylvania School of Medicine
                     address:
                        name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
                     name:Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center
                     address:
                        name:Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gen Sheng Wu
               affiliation:
                     name:Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine
                     address:
                        name:Department of Pathology, Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wafik S El-Deiry
               affiliation:
                     name:University of Pennsylvania School of Medicine
                     address:
                        name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
                     name:Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center
                     address:
                        name:Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway
      description:We previously reported the identification of ONC201/TIC10, a novel small molecule inducer of the human TRAIL gene that improves efficacy-limiting properties of recombinant TRAIL and is in clinical trials in advanced cancers based on its promising safety and antitumor efficacy in several preclinical models. We performed a high throughput luciferase reporter screen using the NCI Diversity Set II to identify TRAIL-inducing compounds. Small molecule-mediated induction of TRAIL reporter activity was relatively modest and the majority of the hit compounds induced low levels of TRAIL upregulation. Among the candidate TRAIL-inducing compounds, TIC9 and ONC201/TIC10 induced sustained TRAIL upregulation and apoptosis in tumor cells in vitro and in vivo. However, ONC201/TIC10 potentiated tumor cell death while sparing normal cells, unlike TIC9, and lacked genotoxicity in normal fibroblasts. Investigating the effects of TRAIL-inducing compounds on cell signaling pathways revealed that TIC9 and ONC201/TIC10, which are the most potent inducers of cell death, exclusively activate Foxo3a through inactivation of Akt/ERK to upregulate TRAIL and its pro-apoptotic death receptor DR5. These studies reveal the selective activity of ONC201/TIC10 that led to its selection as a lead compound for this novel class of antitumor agents and suggest that ONC201/TIC10 is a unique inducer of the TRAIL pathway through its concomitant regulation of the TRAIL ligand and its death receptor DR5.
      datePublished:2015-05-01T00:00:00Z
      dateModified:2024-10-18T00:00:00Z
      pageStart:1
      pageEnd:10
      license:https://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12943-015-0346-9
      keywords:
         ONC201
         TIC10
         TRAIL
         TRAIL-inducing compound
         TNF-related apoptosis-inducing ligand
         DR5
         Foxo3a
         Gene regulation
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-015-0346-9/MediaObjects/12943_2015_346_Fig7_HTML.gif
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:14
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Joshua E Allen
            affiliation:
                  name:University of Pennsylvania School of Medicine
                  address:
                     name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
                  name:Current affiliation: Oncoceutics, Inc.
                  address:
                     name:Current affiliation: Oncoceutics, Inc., Hummelstown, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gabriel Krigsfeld
            affiliation:
                  name:University of Pennsylvania School of Medicine
                  address:
                     name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luv Patel
            affiliation:
                  name:University of Pennsylvania School of Medicine
                  address:
                     name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Patrick A Mayes
            affiliation:
                  name:University of Pennsylvania School of Medicine
                  address:
                     name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David T Dicker
            affiliation:
                  name:University of Pennsylvania School of Medicine
                  address:
                     name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
                  name:Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center
                  address:
                     name:Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gen Sheng Wu
            affiliation:
                  name:Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine
                  address:
                     name:Department of Pathology, Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wafik S El-Deiry
            affiliation:
                  name:University of Pennsylvania School of Medicine
                  address:
                     name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
                  name:Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center
                  address:
                     name:Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:14
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Pennsylvania School of Medicine
      address:
         name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
         type:PostalAddress
      name:Current affiliation: Oncoceutics, Inc.
      address:
         name:Current affiliation: Oncoceutics, Inc., Hummelstown, USA
         type:PostalAddress
      name:University of Pennsylvania School of Medicine
      address:
         name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
         type:PostalAddress
      name:University of Pennsylvania School of Medicine
      address:
         name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
         type:PostalAddress
      name:University of Pennsylvania School of Medicine
      address:
         name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
         type:PostalAddress
      name:University of Pennsylvania School of Medicine
      address:
         name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
         type:PostalAddress
      name:Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center
      address:
         name:Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, USA
         type:PostalAddress
      name:Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine
      address:
         name:Department of Pathology, Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
         type:PostalAddress
      name:University of Pennsylvania School of Medicine
      address:
         name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
         type:PostalAddress
      name:Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center
      address:
         name:Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Joshua E Allen
      affiliation:
            name:University of Pennsylvania School of Medicine
            address:
               name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
               type:PostalAddress
            type:Organization
            name:Current affiliation: Oncoceutics, Inc.
            address:
               name:Current affiliation: Oncoceutics, Inc., Hummelstown, USA
               type:PostalAddress
            type:Organization
      name:Gabriel Krigsfeld
      affiliation:
            name:University of Pennsylvania School of Medicine
            address:
               name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Luv Patel
      affiliation:
            name:University of Pennsylvania School of Medicine
            address:
               name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Patrick A Mayes
      affiliation:
            name:University of Pennsylvania School of Medicine
            address:
               name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:David T Dicker
      affiliation:
            name:University of Pennsylvania School of Medicine
            address:
               name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
               type:PostalAddress
            type:Organization
            name:Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center
            address:
               name:Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Gen Sheng Wu
      affiliation:
            name:Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine
            address:
               name:Department of Pathology, Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
               type:PostalAddress
            type:Organization
      name:Wafik S El-Deiry
      affiliation:
            name:University of Pennsylvania School of Medicine
            address:
               name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
               type:PostalAddress
            type:Organization
            name:Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center
            address:
               name:Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
      name:Current affiliation: Oncoceutics, Inc., Hummelstown, USA
      name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
      name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
      name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
      name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
      name:Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, USA
      name:Department of Pathology, Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
      name:Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, USA
      name:Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, USA

External Links {🔗}(130)

• Find out how much https://www.springernature.com/gp/authors earns monthly
• Profit of https://link.springernature.com/home/
• What's the financial gain of https://order.springer.com/public/cart?
• How much revenue does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research produce monthly?
• How profitable is https://molecular-cancer.biomedcentral.com/about?
• How much does https://submission.nature.com/new-submission/12943/3 net monthly?
• How much does https://doi.org/10.1186/s12943-024-02158-w earn?
• How much does https://doi.org/10.1038%2Fnrc821 bring in each month?
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12189384?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Targeting%20death%20and%20decoy%20receptors%20of%20the%20tumour-necrosis%20factor%20superfamily&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc821&volume=2&pages=420-30&publication_year=2002&author=Ashkenazi%2CA bring in?
• What is the monthly revenue of https://doi.org/10.1016%2F1074-7613%2895%2990057-8?
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8777713?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Identification%20and%20characterization%20of%20a%20new%20member%20of%20the%20TNF%20family%20that%20induces%20apoptosis&journal=Immunity&doi=10.1016%2F1074-7613%2895%2990057-8&volume=3&pages=673-82&publication_year=1995&author=Wiley%2CSR&author=Schooley%2CK&author=Smolak%2CPJ&author=Din%2CWS&author=Huang%2CCP&author=Nicholl%2CJK?
• Get to know what's the income of https://doi.org/10.1084%2Fjem.190.8.1155
• How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195665 produce monthly?
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10523613
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Human%20dendritic%20cells%20mediate%20cellular%20apoptosis%20via%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20%28Trail%29&journal=J%20Exp%20Med&doi=10.1084%2Fjem.190.8.1155&volume=190&pages=1155-64&publication_year=1999&author=Fanger%2CNA&author=Maliszewski%2CCR&author=Schooley%2CK&author=Griffith%2CTS
• How much does https://doi.org/10.1084%2Fjem.189.8.1343 pull in monthly?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193036
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10209050 produce monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Monocyte-mediated%20tumoricidal%20activity%20via%20the%20tumor%20necrosis%20factor-related%20cytokine%2C%20TRAIL&journal=J%20Exp%20Med&doi=10.1084%2Fjem.189.8.1343&volume=189&pages=1343-54&publication_year=1999&author=Griffith%2CTS&author=Wiley%2CSR&author=Kubin%2CMZ&author=Sedger%2CLM&author=Maliszewski%2CCR&author=Fange%2CNA gross monthly?
• Revenue of https://doi.org/10.4049%2Fjimmunol.173.2.892
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15240676?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Human%20B%20cells%20express%20functional%20TRAIL%2FApo-2%20ligand%20after%20CpG-containing%20oligodeoxynucleotide%20stimulation&journal=J%20Immunol&doi=10.4049%2Fjimmunol.173.2.892&volume=173&pages=892-9&publication_year=2004&author=Kemp%2CTJ&author=Moore%2CJM&author=Griffith%2CTS?
• What's the financial intake of https://doi.org/10.1084%2Fjem.188.12.2375?
• How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212426 generate?
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9858524?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Natural%20Killer%20%28NK%29%20cell-mediated%20cytotoxicity%3A%20differential%20use%20of%20TRAIL%20and%20fas%20ligand%20by%20immature%20and%20mature%20primary%20human%20NK%20cells&journal=J%20Exp%20Med&doi=10.1084%2Fjem.188.12.2375&volume=188&pages=2375-80&publication_year=1998&author=Zamai%2CL&author=Ahmad%2CM&author=Bennett%2CIM&author=Azzoni%2CL&author=Alnemri%2CES&author=Perussia%2CB?
• How much revenue does https://doi.org/10.1016%2Fj.lungcan.2007.12.011 produce monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18255187 make?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Phase%202%20study%20of%20mapatumumab%2C%20a%20fully%20human%20agonistic%20monoclonal%20antibody%20which%20targets%20and%20activates%20the%20TRAIL%20receptor-1%2C%20in%20patients%20with%20advanced%20non-small%20cell%20lung%20cancer&journal=Lung%20Cancer&doi=10.1016%2Fj.lungcan.2007.12.011&volume=61&pages=82-90&publication_year=2008&author=Greco%2CFA&author=Bonomi%2CP&author=Crawford%2CJ&author=Kelly%2CK&author=Oh%2CY&author=Halpern%2CW
• Income figures for https://doi.org/10.1158%2F1078-0432.CCR-09-1267
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20145186 generate monthly?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20safety%20and%20pharmacokinetic%20study%20of%20the%20death%20receptor%205%20agonistic%20antibody%20PRO95780%20in%20patients%20with%20advanced%20malignancies&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-09-1267&volume=16&pages=1256-63&publication_year=2010&author=Camidge%2CDR&author=Herbst%2CRS&author=Gordon%2CMS&author=Eckhardt%2CSG&author=Kurzrock%2CR&author=Durbin%2CB?
• What is the earnings of https://doi.org/10.1038%2Fsj.bjc.6605507?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822942 pull in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20068564 generate monthly?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Phase%20II%20trial%20of%20mapatumumab%2C%20a%20fully%20human%20agonistic%20monoclonal%20antibody%20that%20targets%20and%20activates%20the%20tumour%20necrosis%20factor%20apoptosis-inducing%20ligand%20receptor-1%20%28TRAIL-R1%29%2C%20in%20patients%20with%20refractory%20colorectal%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6605507&volume=102&pages=506-12&publication_year=2010&author=Trarbach%2CT&author=Moehler%2CM&author=Heinemann%2CV&author=K%C3%B6hne%2CCH&author=Przyborek%2CM&author=Schulz%2CC
• How much income does https://doi.org/10.1158%2F1078-0432.CCR-09-0996 have?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19690193?
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Mapatumumab%2C%20a%20fully%20human%20agonistic%20monoclonal%20antibody%20that%20targets%20TRAIL-R1%2C%20in%20combination%20with%20gemcitabine%20and%20cisplatin%3A%20a%20phase%20I%20study&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-09-0996&volume=15&pages=5584-90&publication_year=2009&author=Mom%2CCH&author=Verweij%2CJ&author=Oldenhuis%2CCN&author=Gietema%2CJA&author=Fox%2CNL&author=Miceli%2CR?
• What's the income of https://doi.org/10.1200%2FJCO.2008.21.7422?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19652058 make?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Mapatumumab%2C%20an%20antibody%20targeting%20TRAIL-R1%2C%20in%20combination%20with%20paclitaxel%20and%20carboplatin%20in%20patients%20with%20advanced%20solid%20malignancies%3A%20results%20of%20a%20phase%20I%20and%20pharmacokinetic%20study&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.21.7422&volume=27&pages=4413-21&publication_year=2009&author=Leong%2CS&author=Cohen%2CRB&author=Gustafson%2CDL&author=Langer%2CCJ&author=Camidge%2CDR&author=Padavic%2CK?
• What's https://doi.org/10.1158%2F1078-0432.CCR-07-0950's gross income?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17947486 earns monthly
• Profit of http://scholar.google.com/scholar_lookup?&title=Phase%201%20and%20pharmacokinetic%20study%20of%20lexatumumab%20in%20patients%20with%20advanced%20cancers&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-0950&volume=13&pages=6187-94&publication_year=2007&author=Plummer%2CR&author=Attard%2CG&author=Pacey%2CS&author=Li%2CL&author=Razak%2CA&author=Perrett%2CR
• Learn how profitable https://doi.org/10.1200%2FJCO.2006.08.8898 is on a monthly basis
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17416859 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Phase%20I%20pharmacokinetic%20and%20biologic%20correlative%20study%20of%20Mapatumumab%2C%20a%20fully%20human%20monoclonal%20antibody%20with%20agonist%20activity%20to%20tumor%20necrosis%20factor%20related%20apoptosis-inducing%20ligand%20receptor-1&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.08.8898&volume=25&pages=1390-6&publication_year=2007&author=Tolcher%2CAW&author=Mita%2CM&author=Meropol%2CNJ&author=Mehren%2CM&author=Patnaik%2CA&author=Padavic%2CK pull in?
• How much does https://doi.org/10.1517%2F14728222.2010.519701 generate monthly?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20819019?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=TRAIL%20receptor%20signaling%20and%20therapeutics&journal=Expert%20Opin%20Ther%20Targets&doi=10.1517%2F14728222.2010.519701&volume=14&pages=1091-108&publication_year=2010&author=Abdulghani%2CJ&author=El-Deiry%2CWS is on a monthly basis
• Revenue of https://doi.org/10.1158%2F1535-7163.MCT-10-0621
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20924127 making per month?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=A%20Better%20TRAIL%20Variant%20for%20Tumor%20Cell-Specific%20Targeting%3F%20-%20Letter&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-10-0621&volume=9&publication_year=2010&author=Bremer%2CE&author=Helfrich%2CW?
• What's the total monthly financial gain of https://doi.org/10.1038%2F5517?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9930862?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20in%20vivo&journal=Nat%20Med&doi=10.1038%2F5517&volume=5&pages=157-63&publication_year=1999&author=Walczak%2CH&author=Miller%2CRE&author=Ariail%2CK&author=Gliniak%2CB&author=Griffith%2CTS&author=Kubin%2CM make?
• Income figures for https://doi.org/10.1158%2F1078-0432.CCR-05-2635
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16638878 have?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Preclinical%20differentiation%20between%20apparently%20safe%20and%20potentially%20hepatotoxic%20applications%20of%20TRAIL%20either%20alone%20or%20in%20combination%20with%20chemotherapeutic%20drugs&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-2635&volume=12&pages=2640-6&publication_year=2006&author=Ganten%2CTM&author=Koschny%2CR&author=Sykora%2CJ&author=Schulze-Bergkamen%2CH&author=B%C3%BCchler%2CP&author=Haas%2CTL
• How much income does https://doi.org/10.1158%2F1535-7163.MCT-12-0366 have?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22802267?
• How much does http://scholar.google.com/scholar_lookup?&title=Targeting%20TRAIL%20death%20receptor%204%20with%20trivalent%20DR4%20Atrimer%20complexes&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-12-0366&volume=11&pages=2087-95&publication_year=2012&author=Allen%2CJE&author=Ferrini%2CR&author=Dicker%2CDT&author=Batzer%2CG&author=Chen%2CE&author=Oltean%2CDI bring in each month?
• How much does https://doi.org/10.1002%2Fstem.136 generate monthly?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19544410 earning monthly?
• http://scholar.google.com/scholar_lookup?&title=Human%20bone%20marrow-derived%20mesenchymal%20stromal%20cells%20expressing%20S-TRAIL%20as%20a%20cellular%20delivery%20vehicle%20for%20human%20glioma%20therapy&journal=Stem%20Cells&doi=10.1002%2Fstem.136&volume=27&pages=2320-30&publication_year=2009&author=Menon%2CLG&author=Kelly%2CK&author=Yang%2CHW&author=Kim%2CSK&author=Black%2CPM&author=Carroll%2CRS income
• Earnings of https://doi.org/10.1038%2Fnchembio.1153
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23292651?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Small-molecule%20activation%20of%20the%20TRAIL%20receptor%20DR5%20in%20human%20cancer%20cells&journal=Nat%20Chem%20Biol&doi=10.1038%2Fnchembio.1153&volume=9&pages=84-9&publication_year=2013&author=Wang%2CG&author=Wang%2CX&author=Yu%2CH&author=Wei%2CS&author=Williams%2CN&author=Holmes%2CDL?
• How much does https://doi.org/10.4161%2Fcbt.21354 pull in?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20the%20human%20TRAIL%20gene&journal=Canc%20Biol%20Ther&doi=10.4161%2Fcbt.21354&volume=13&pages=1143-51&publication_year=2012&author=Allen%2CJE&author=El-Deiry%2CWS
• How much does https://doi.org/10.4161%2Fcbt.7.12.7460 pull in monthly?
• http://scholar.google.com/scholar_lookup?&title=TNFSF10%20%28TRAIL%29%2C%20a%20p53%20target%20gene%20that%20mediates%20p53-dependent%20cell%20death&journal=Canc%20Biol%20Ther&doi=10.4161%2Fcbt.7.12.7460&volume=7&pages=2034-8&publication_year=2008&author=Kuribayashi%2CK&author=Krigsfeld%2CG&author=Wang%2CW&author=Xu%2CJ&author=Mayes%2CPA&author=Dicker%2CDT income
• Revenue of https://doi.org/10.1073%2Fpnas.0731871100
• How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC164479 make?
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12750477
• Find out how much http://scholar.google.com/scholar_lookup?&title=Cytokines%20and%20BCR-ABL%20mediate%20suppression%20of%20TRAIL-induced%20apoptosis%20through%20inhibition%20of%20forkhead%20FOXO3a%20transcription%20factor&journal=Proc%20Natl%20Acad%20Sci&doi=10.1073%2Fpnas.0731871100&volume=100&pages=6523-8&publication_year=2003&author=Ghaffari%2CS&author=Jagani%2CZ&author=Kitidis%2CC&author=Lodish%2CHF&author=Khosravi-Far%2CR earns monthly
• How much money does https://doi.org/10.1172%2FJCI6863 generate?
• Profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC408422
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10430607?
• How much does http://scholar.google.com/scholar_lookup?&title=Disruption%20of%20p53%20in%20human%20cancer%20cells%20alters%20the%20responses%20to%20therapeutic%20agents&journal=J%20Clin%20Investig&doi=10.1172%2FJCI6863&volume=104&pages=263-9&publication_year=1999&author=Bunz%2CF&author=Hwang%2CPM&author=Torrance%2CC&author=Waldman%2CT&author=Zhang%2CY&author=Dillehay%2CL pull in?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11486001's financial summary
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Identification%20of%20Inhibitors%20of%20TRAIL-induced%20Death%20%28ITIDs%29%20in%20the%20TRAIL-sensitive%20colon%20carcinoma%20cell%20line%20SW480%20using%20a%20genetic%20approach&journal=J%20Biol%20Chem&volume=276&pages=37879-86&publication_year=2001&author=Burns%2CTF&author=El-Deiry%2CWS
• How much profit is https://doi.org/10.1126%2Fscitranslmed.3004828 making per month?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23390247's total income per month
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Dual%20inactivation%20of%20Akt%20and%20ERK%20by%20TIC10%20signals%20Foxo3a%20nuclear%20translocation%2C%20TRAIL%20gene%20induction%20and%20potent%20anti-tumor%20effects&journal=Sci%20Transl%20Med&doi=10.1126%2Fscitranslmed.3004828&volume=5&publication_year=2013&author=Allen%2CJE&author=Krigsfeld%2CG&author=Mayes%2CPA&author=Patel%2CL&author=Dicker%2CDT&author=Patel%2CAS
• What's the financial intake of https://doi.org/10.1053%2Fj.gastro.2011.06.026?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21699898 earns monthly
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Oxaliplatin%20uses%20JNK%20to%20restore%20TRAIL%20sensitivity%20in%20cancer%20cells%20through%20Bcl-xL%20inactivation&journal=Gastroenterology&doi=10.1053%2Fj.gastro.2011.06.026&volume=141&pages=430-4&publication_year=2011&author=Allen%2CJE&author=El-Deiry%2CWS
• How much revenue does https://doi.org/10.1038%2Fng1097-141 bring in?
• How much does http://scholar.google.com/scholar_lookup?&title=KILLER%2FDR5%20is%20a%20DNA%20damage-inducible%20p53-regulated%20death%20receptor%20gene&journal=Nat%20Genet&doi=10.1038%2Fng1097-141&volume=17&pages=141-3&publication_year=2014&author=Wu%2CGS&author=Burns%2CTF&author=McDonald%2CER&author=Jiang%2CW&author=Meng%2CR&author=Krantz%2CID bring in each month?
• How much income does http://scholar.google.com/scholar_lookup?&title=Is%20a%20potent%20inducer%20of%20apoptosis%20in%20human%20cancer%20cells%20independently%20of%20p53&journal=Exp%20Cell%20Res&volume=2&pages=190-6&publication_year=2014&author=Shao%2CR-G&author=Shimizu%2CT&author=Pommier%2CY&author=Brefeldin%2CA have?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=ONC201%20induces%20p53-independent%20apoptosis%20and%20cell%20cycle%20arrest%20in%20hematological%20malignancies%20and%20leukemic%20stem%2Fprogenitor%20cells%20by%20inducing%20ER%20stress%20and%20mTOR%20inhibition&journal=Blood&volume=124&publication_year=2014&author=Ishizawa%2CJ&author=Kojima%2CK&author=Chachad%2CD&author=Ruvolo%2CPP&author=Ruvolo%2CVR&author=Jacamo%2CR
• Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350349
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25587031 earning monthly?
• How profitable is http://scholar.google.com/scholar_lookup?&title=The%20angular%20structure%20of%20ONC201%2C%20a%20TRAIL%20pathway-inducing%20compound%2C%20determines%20its%20potent%20anti-cancer%20activity&journal=Oncotarget&volume=5&pages=12728-37&publication_year=2014&author=Wagner%2CJ&author=Kline%2CCL&author=Pottorf%2CRS&author=Nallaganchu%2CBR&author=Olson%2CGL&author=Dicker%2CDT?
• How much revenue does https://citation-needed.springer.com/v2/references/10.1186/s12943-015-0346-9?format=refman&flavour=references generate?
• What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Joshua%20E%20Allen?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Joshua%20E%20Allen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gabriel%20Krigsfeld earns monthly
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gabriel%20Krigsfeld%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Luv%20Patel
• What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Luv%20Patel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Patrick%20A%20Mayes?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Patrick%20A%20Mayes%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=David%20T%20Dicker?
• What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22David%20T%20Dicker%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gen%20Sheng%20Wu
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gen%20Sheng%20Wu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wafik%20S%20El-Deiry have monthly?
• How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wafik%20S%20El-Deiry%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
• https://crossmark.crossref.org/dialog/?doi=10.1186/s12943-015-0346-9's financial summary
• How much cash flow does https://citation-needed.springer.com/v2/references/10.1186/s12943-015-0346-9?format=refman&flavour=citation have monthly?
• How much money does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral generate?
• Financial intake of https://www.springernature.com/gp/products
• How much income is https://www.springernature.com/gp/librarians earning monthly?
• What's the financial intake of https://www.springernature.com/gp/societies?
• Find out how much https://www.springernature.com/gp/partners earns monthly
• How much revenue does https://www.springer.com/ produce monthly?
• How much revenue does https://www.nature.com/ generate?
• Discover the revenue of https://www.biomedcentral.com/
• What is the earnings of https://www.palgrave.com/?
• How much revenue does https://www.apress.com/ generate?
• How much cash flow does https://www.springernature.com/gp/legal/ccpa have monthly?
• What's the financial outcome of https://www.springernature.com/gp/info/accessibility?
• How much does https://support.springernature.com/en/support/home net monthly?
• How much profit does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations make?
• Get to know https://www.springernature.com/'s earnings

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref